tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market
Want to see CH:BSLN full AI Analyst Report?

Basilea Pharmaceutica (BSLN) Technical Analysis

7 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
5Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is 0.71, suggesting Basilea Pharmaceutica is a Sell.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 54.29, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 53.82, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.

Basilea Pharmaceutica (BSLN) Pivot Points

May 07, 2026, 06:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
51.53
52.97
54.03
55.47
56.53
57.97
59.03
Fibonacci
52.97
53.92
54.51
55.47
56.42
57.01
57.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

May 07, 2026, 06:00 PM
Period
Simple
Exponential
MA5
55.78Buy
55.62Buy
MA10
54.89Buy
55.02Buy
MA20
53.66Buy
54.29Buy
MA50
54.10Buy
53.82Buy
MA100
53.53Buy
53.01Buy
MA200
51.21Buy
51.06Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 55.02, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 53.01, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 54.10, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 53.53, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 51.21, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

May 07, 2026, 06:00 PM
Name
Value
Implied Action
RSI (14)
59.48
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
71.74
Neutral
MACD (12,26)
0.71
Sell
ADX (14)
14.84
Buy
Williams %R
-27.87
Buy
CCI (14)
93.96
Neutral
ATR (14)
1.61
-
Ultimate Oscillator
50.95
Neutral
ROC
6.86
Buy
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 59.48, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 14.84, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is 93.96, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is 6.86, creating a Buy signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Strong Buy.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 59.48, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is 0.71, which suggests BSLN is a Sell.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 55.78, which suggests BSLN is a Buy.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 53.66, which suggests BSLN is a Buy.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 54.10, which suggests BSLN is a Buy.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 51.21, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -27.87, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is 93.96, which suggests BSLN is a Neutral.
                    What is the share price of Basilea Pharmaceutica?